Description
An inhibitor of the MDM2-p53 interaction (IC50 = 0.018 µM); inhibits proliferation in cancer cell lines expressing wild-type p53 (IC50s = 0.18-2.2 µM) and cell lines expressing mutant p53 (IC50s = 5.7-20.3 µM); prevents and reduces tumor growth in an SJSA-1 mouse xenograft model at 50 and 100 mg/kg per day, respectively; decreases platelet counts in rats at 50 and 100 mg/kg and in cynomolgus monkeys at 10 and 20 mg/kg
Formal name: [(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl][4-[3-(methylsulfonyl)propyl]-1-piperazinyl]-methanone
Synonyms: RO5045337
Molecular weight: 727.8
CAS: 939981-39-2
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Ubiquitin Ligase System||Research Area|Cancer|Cell Signaling|p53 Signaling||Research Area|Cancer|Transcription Factors|p53||Research Area|Cell Biology|Proteolysis|Ubiquitin/Proteasome System